Parkinson's Disease Trial, Recruiting (NCT07204652)

Parkinson's Disease Trial, Recruiting NCT07204652 Sponsor: CND Life Sciences Condition: Parkinson's Disease

Printed from Voxsanity (voxsanity.com.au) — NCT07204652 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Parkinsons Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Adults between the ages of 40 and 99 years old
People who have been officially diagnosed with Parkinson's disease using a specific set of recognized diagnostic guidelines
People who have already agreed to have a routine colonoscopy, either as part of regular colon cancer screening or to check for other digestive system conditions

Who may not be able to join:

People who take blood-thinning medications (note: Plavix 75 mg or aspirin up to 325 mg on its own may be allowed — confirm with trial site)
People who have a history of colon cancer
People who have recently had a digestive illness or surgery involving the digestive system (confirm with trial site for specific timeframes)
People who are pregnant or planning to become pregnant before their scheduled colonoscopy
People with significant memory or thinking difficulties, as judged by the research team
People who are unable to understand and confirm that taking part in this study is their own voluntary choice and is for research purposes

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 14 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Delaram Safarpour, MD, MSCE, FAAN, Oregon Health and Science University

Phone: 503-501-8478

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07204652

Sponsor: CND Life Sciences

Phase: Not Applicable

Status: Recruiting

Condition: Parkinson's Disease

Trial contact: 503-501-8478

More information: https://clinicaltrials.gov/study/NCT07204652

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Adults between the ages of 40 and 99 years old
People who have been officially diagnosed with Parkinson's disease using a specific set of recognized diagnostic guidelines
People who have already agreed to have a routine colonoscopy, either as part of regular colon cancer screening or to check for other digestive system conditions

Who may not be able to join:

People who take blood-thinning medications (note: Plavix 75 mg or aspirin up to 325 mg on its own may be allowed — confirm with trial site)
People who have a history of colon cancer
People who have recently had a digestive illness or surgery involving the digestive system (confirm with trial site for specific timeframes)
People who are pregnant or planning to become pregnant before their scheduled colonoscopy
People with significant memory or thinking difficulties, as judged by the research team
People who are unable to understand and confirm that taking part in this study is their own voluntary choice and is for research purposes

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 14 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

CND Life Sciences

Registry

ClinicalTrials.gov

Start date

3 September 2025

Est. completion

1 September 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Detection of phosphorylated alpha-synuclein in colon tissue samples

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov